94 results
Page 2 of 5
8-K
EX-99.1
n6rj0lrly59
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am
8-K
EX-99.1
rnw2lb mizbl7nhr
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
EX-99.1
mj1dtpzqhe5zl5zc
10 Aug 23
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
4:14pm
8-K
EX-99.1
zho746b
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
uriut7mvrcm2tlygx
10 May 23
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
9:20am
8-K
EX-99.1
xek15dxiz9n22pmz8ky
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
EX-99.1
kd5xk iw4v
30 Mar 23
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
4:15pm
8-K
EX-99.1
47vfvp
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
EX-99.1
0spadfz4dmrp e2
10 Aug 22
Pulse Biosciences Reports Second Quarter 2022 Financial Results
4:15pm
CORRESP
wqi yt85fgb2vviy6d
14 Jul 22
Correspondence with SEC
12:00am
8-K
EX-99.1
vnrom0x26vtml
9 Jun 22
Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
4:58pm
CORRESP
qqslz2z8e3fowxfgzxo5
9 Jun 22
Correspondence with SEC
12:00am
8-K
EX-99.1
mvwmckn 50lyiv
3 Jun 22
Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
4:05pm
UPLOAD
28e7xx
25 May 22
Letter from SEC
12:00am